EMD Serono has appointed Joseph Leveque as chief medical officer in the US.
Dr Leveque will be responsible for working with the regulatory, medical and development teams to enhance EMD Serono’s clinical presence in the US and to drive the execution of key medical initiatives.
Leveque brings over 20 years of experience in areas of strategic leadership, advancing medical and clinical programs, as well as life cycle management.
Paris Panayiotopoulos, president and managing director of EMD Serono, said: “Dr. Leveque’s substantial experience in managing integrated global medical affairs teams will be significant to furthering our specialty care focus in neurology, oncology, fertility, and endocrinology and bringing our pipeline forward.”
Leveque formerly served at Bristol-Myers Squibb, where he was the head of US Medical for Oncology. During his time there, he was responsible for providing strategic leadership and management for marketed and near-term pipeline oncology assets.